New Atezolizumab Formulation for Subcutaneous Injection
The FDA approved atezolizumab and hyaluronidase-tqjs for all adult indications of intravenous atezolizumab. The U.S. Food and Drug Administration...
Progress Against Cancer
The FDA approved atezolizumab and hyaluronidase-tqjs for all adult indications of intravenous atezolizumab. The U.S. Food and Drug Administration...
The FDA approved lazertinib plus amivantamab-vmjw for the treatment of certain EGFR-mutated lung cancers. The U.S. Food and Drug...
Durvalumab can now be used with chemotherapy for certain patients with resectable non-small cell lung cancer. The U.S. Food...
The FDA approved axatilimab-csfr, an inhibitor of monocytes and macrophages, for certain patients with chronic graft-versus-host disease. The U.S....
The FDA has approved vorasidenib to treat certain brain tumors harboring an IDH1 or IDH2 mutation. The U.S. Food...
Afamitresgene autoleucel has received accelerated approval to treat certain patients with synovial sarcoma. The U.S. Food and Drug Administration...
The FDA has approved dostarlimab-gxly plus chemotherapy to treat more patients with endometrial cancer. The U.S. Food and Drug...
The targeted therapy was approved by the FDA for use in combination with bortezomib, lenalidomide, and dexamethasone. The U.S....
The FDA approved the immunotherapy epcoritamab-bysp for certain patients with follicular lymphoma. The U.S. Food and Drug Administration (FDA)...
The FDA issued its first approval for the use of A KRAS G12C inhibitor in a tumor type other...